Navigation Links
Dynatronics Selected for Inclusion in RB Milestone Portfolio

SALT LAKE CITY, March 16, 2011 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) announced that it has been selected for inclusion in the RB Milestone Portfolio, a group of companies selected by RB Milestone Group, LLC ("RBMG"), to be introduced to the market via a combination of traditional and innovative analytical and communication strategies including equity research, The Portal Network™, and non-deal roadshows, with a focus on the healthcare, mining, energy, and technology sectors.

The Portal Network™, RBMG's web-based platform, provides cutting-edge communications solutions that are believed by RBMG to outperform more traditional efforts. In addition to an array of proprietary equity research, RBMG members, including corporate executives and sophisticated investors, also have access to the interactive tools intended to assist them to communicate more efficiently with other key industry players.

News and discussions pertaining to Dynatronics can now be followed at RBMG's Portal Network™ by the following link:

About RB Milestone Group

RB Milestone Group (RBMG) is a Wall Street-based equity research firm that provides a variety of cutting-edge equity research solutions through its proprietary platform, The Portal Network™. This web-based platform is a premier interactive research hub, which, according to RBMG, has proven to outperform the effectiveness of traditional research solutions and coverage communications efforts. RBMG's network presently totals approximately 1,100 flagship institutional and high net worth members. RBMG only accepts a select number of companies into their coverage network in a given year, and those who are admitted into the RB Milestone Portfolio are deemed by RBMG to be significantly undervalued on a fundamental and technical analysis basis.

About Dynatronics

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at  

This press release contains forward-looking statements. Those statements include references to future events and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2010.

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
2. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
3. Dynatronics Regains Compliance With NASDAQ
4. Dynatronics to Release Second Quarter Results Monday, February 1, 2010; Conference Call Set for 1:30 p.m. ET
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
7. Dynatronics Announces Positive Financial Results for Quarter
8. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
9. Dynatronics Receives 180-Day NASDAQ Extension
10. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
11. Dynatronics to Release Third Quarter Results Monday, May 17, 2010; Conference Call Set for 1:30 p.m. ET
Post Your Comments:
(Date:11/29/2015)... Germany , Nov. 29, 2015 /PRNewswire/ ... Imaging invites attendees to experience the most complete mobile ... highlight on display is Ziehm Vision RFD 3D, the ... a 16 cm edge length per scan volume. In ... the first fully motorized mobile C-arm in four axes ...
(Date:11/27/2015)... 2015 Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... Une nouvelle approche consistant à combiner l,immunothérapie au ...    Clinical Cancer Research . ...
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
Breaking Medicine Technology:
(Date:11/29/2015)... Raleigh, NC (PRWEB) , ... November 29, 2015 , ... ... calling on their colleagues to recognize the signs of mesothelioma and push for a ... the report on its website. Click here to read it now. ...
(Date:11/28/2015)... ... November 28, 2015 , ... StatRad ... has added Chris Hafey and Claude Hooton to its board of directors. The ... North America (RSNA) 2015 Annual Meeting and continues to strategically transform its focus ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Pixel Film ... customizable media panels to choose from, the possibilities are endless. Users have full control ... With the ProPanel: Pulse masking effects, users are sure to get heads to turn. ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, while ... light of the recent terrorist attacks in Paris, other cities are taking extra precautions ... reaching U.S. soil. Especially around special events that may be high-profile in nature, the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
Breaking Medicine News(10 mins):